Table: Aska Pharmaceutical -Q1 group results

ASKA Pharmaceutical Holdings

05/08/2019 07:00

Aug 5 (Reuters)- 
             Aska Pharmaceutical Co Ltd 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 3 months ended      3 months ended       Year to 
                Jun 30, 2019        Jun 30, 2018     Mar 31, 2020 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales             13.99               12.76            53.00    
                 (+9.6 pct)          (-0.4 pct)       (+13.5 pct) 
  Operating        837 mln               1.22             2.00    
                 (-31.2 pct)         (+13.1 pct)      (+12.2 pct) 
  Recurring        969 mln               1.36             2.10    
                 (-28.4 pct)         (+15.5 pct)      (+6.1 pct)  
  Net              563 mln               1.06             1.00    
                 (-46.9 pct)         (+1.8 pct)       (-42.7 pct) 
  EPS             19.96 yen           37.67 yen        35.41 yen  
  Ann Div                             14.00 yen        14.00 yen  
  -Q2 div                             7.00 yen         7.00 yen   
  -Q4 div                             7.00 yen         7.00 yen   
  
  NOTE - Aska Pharmaceutical Co Ltd. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T